In November 2022, Australia's medical regulatory company, the Therapeutic Products Administration (TGA) claimed that there was a global shortage in the diabetes medication Ozempic. According to the TGA, the rise in desire was a result of an increase in off-label prescription of your drug for fat reduction needs.[316] In December 2022, with The usa